Joshua Feder, MD

How Effective is Atomoxetine in Children and Adolescents

June 27, 2022

With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine.

Assessing Bipolar Disorder in Youth

May 30, 2022

Joshua Feder, MD and Mara Goverman

The validity of bipolar disorder in children and adolescents has long been debated, and the history surrounding this diagnosis is controversial to say the least. In this podcast, we will discuss the evidence supporting whether bipolar disorder presents in youth, and how clinicians can best assess this disorder.

How to Use Equine-Assisted Psychotherapy

May 16, 2022

Joshua Feder, MD and Mara Goverman

When patients are not amenable to usual therapy, equine-assisted psychotherapy (EAP) might be a good option. In this podcast, we’ll talk about working with horses as an alternative to, or in conjunction with, traditional therapy.

Treating Children of Divorce

March 17, 2022

Joshua Feder, MD and Mara Goverman

Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children, and it may not be the divorce itself that is hard on children, but how the divorce is handled. How can we navigate the complexities of treating a child with divorced or separated parents?

Do Antipsychotics Have Neurotoxic Effects in Youth?

March 4, 2022

Joshua Feder, MD and Mara Goverman

Do antipsychotics have neurotoxic effects in youth? In this episode, we’ll be banging the drum of caution about antipsychotic use in children and adolescents.

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook with CME Post-Test Access

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook Access and CME Post-Test

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Note From the Editor-in-Chief

May 20, 2021

Joshua Feder, MD

Joshua Feder, MD

At Carlat we dig deeper: Last fall it was the possibility of suicidality with antidepressants when we see the real data; this winter, it was the lack of clinical relevance of CYP enzyme testing when we use medications carefully; and this spring, beneath the apparent weight of thousands of studies that turn out to be flawed, we found an absence of a definable effect size for the massive $17 billion applied behavioral analysis industry.

Note From the Editor-in-Chief

March 12, 2021

Joshua Feder, MD

Josh Feder, MD Dr. Feder has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this first issue of 2021, we dig deeper into current and chronic areas of clinical complexity. Genetic testing can find identifiable disorders, offering relief to families searching for answers and perhaps guiding future treatment. Despite the hype, though, pharmacogenetics has limitations; we need to know what it can and...

Note from the Editor-in-Chief

August 5, 2020

Joshua Feder, MD

Josh Feder, MD Dr. Feder has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As we head back into our homes in the midst of bungled reopenings and anguished protests, we at CCPR are striving to more consciously address social determinants and inequities. In this long-planned issue on culture, we talk about approaches to understanding cultural diversity in our everyday practice, the risks and...